Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bucher

Showing results (301-310 of 406) with videos related to

Pageof 41
Sort By:
HIV Medicine|October 20, 2010
Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort StudyJ Young, A U Scherrer, H F Günthard, et al.
Trials|September 21, 2018
The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: Rationale and design of the database and the collection of evidence available at approval of novel drugsAviv Ladanie, Benjamin Speich, Florian Naudet, et al.
European Journal of Epidemiology|April 3, 2013
Design and methodology of the Swiss Transplant Cohort Study (STCS): a comprehensive prospective nationwide long-term follow-up cohortMichael T Koller, Christian van Delden, Nicolas J Müller, et al.
The Cochrane Database of Systematic Reviews|June 17, 2011
Statins for acute coronary syndromeNoah Vale, Alain J Nordmann, Gregory G Schwartz, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 4, 2015
Combination therapy for multidrug-resistant cytomegalovirus diseaseC Stuehler, G Stüssi, J Halter, et al.
Health Economics Review|November 5, 2022
Shaping a research agenda to ensure a successful European health technology assessment: insights generated during the inaugural convention of the European access academyElaine Julian, Mira Pavlovic, Oriol Sola-Morales, et al.
International Journal of Cardiology|February 8, 2011
Updated evidence on early statin therapy for acute coronary syndromes: meta-analysis of 18 randomized trials involving over 14,000 patientsMatthias Briel, Noah Vale, Gregory G Schwartz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2010
Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?, Amanda Mocroft, Peter Reiss, et al.
Annals of Internal Medicine|September 19, 2012
Development and validation of a coronary risk prediction model for older U.S. and European persons in the Cardiovascular Health Study and the Rotterdam StudyMichael T Koller, Maarten J G Leening, Marcel Wolbers, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 21, 2009
Implementation of raltegravir in routine clinical practice: selection criteria for choosing this drug, virologic response rates, and characteristics of failuresAlexandra U Scherrer, Viktor von Wyl, Christof A Fux, et al.
Pageof 41

Showing results (301-310 of 406) with videos related to

Sort By:
Pageof 41
HIV Medicine|October 20, 2010
Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort StudyJ Young, A U Scherrer, H F Günthard, et al.
Trials|September 21, 2018
The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: Rationale and design of the database and the collection of evidence available at approval of novel drugsAviv Ladanie, Benjamin Speich, Florian Naudet, et al.
European Journal of Epidemiology|April 3, 2013
Design and methodology of the Swiss Transplant Cohort Study (STCS): a comprehensive prospective nationwide long-term follow-up cohortMichael T Koller, Christian van Delden, Nicolas J Müller, et al.
The Cochrane Database of Systematic Reviews|June 17, 2011
Statins for acute coronary syndromeNoah Vale, Alain J Nordmann, Gregory G Schwartz, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 4, 2015
Combination therapy for multidrug-resistant cytomegalovirus diseaseC Stuehler, G Stüssi, J Halter, et al.
Health Economics Review|November 5, 2022
Shaping a research agenda to ensure a successful European health technology assessment: insights generated during the inaugural convention of the European access academyElaine Julian, Mira Pavlovic, Oriol Sola-Morales, et al.
International Journal of Cardiology|February 8, 2011
Updated evidence on early statin therapy for acute coronary syndromes: meta-analysis of 18 randomized trials involving over 14,000 patientsMatthias Briel, Noah Vale, Gregory G Schwartz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2010
Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?, Amanda Mocroft, Peter Reiss, et al.
Annals of Internal Medicine|September 19, 2012
Development and validation of a coronary risk prediction model for older U.S. and European persons in the Cardiovascular Health Study and the Rotterdam StudyMichael T Koller, Maarten J G Leening, Marcel Wolbers, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 21, 2009
Implementation of raltegravir in routine clinical practice: selection criteria for choosing this drug, virologic response rates, and characteristics of failuresAlexandra U Scherrer, Viktor von Wyl, Christof A Fux, et al.
Pageof 41